220 related articles for article (PubMed ID: 15853691)
1. Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applications.
Verma AK; Sachin K; Saxena A; Bohidar HB
Curr Pharm Biotechnol; 2005 Apr; 6(2):121-30. PubMed ID: 15853691
[TBL] [Abstract][Full Text] [Related]
2. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
[TBL] [Abstract][Full Text] [Related]
3. The role of metal nanoparticles in remote release of encapsulated materials.
Skirtach AG; Dejugnat C; Braun D; Susha AS; Rogach AL; Parak WJ; Möhwald H; Sukhorukov GB
Nano Lett; 2005 Jul; 5(7):1371-7. PubMed ID: 16178241
[TBL] [Abstract][Full Text] [Related]
4. Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells.
Yadav D; Anwar MF; Garg V; Kardam H; Beg MN; Suri S; Gaur S; Asif M
Asian Pac J Cancer Prev; 2014; 15(5):2335-40. PubMed ID: 24716980
[TBL] [Abstract][Full Text] [Related]
5. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
6. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M
Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
9. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Ofokansi K; Winter G; Fricker G; Coester C
Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
[TBL] [Abstract][Full Text] [Related]
10. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
11. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate.
Bajpai AK; Choubey J
J Mater Sci Mater Med; 2006 Apr; 17(4):345-58. PubMed ID: 16617413
[TBL] [Abstract][Full Text] [Related]
12. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
13. Preparation and optimization of monodisperse polymeric microparticles using modified vibrating orifice aerosol generator for controlled delivery of letrozole in breast cancer therapy.
Alemrayat B; Elrayess MA; Alany RG; Elhissi A; Younes HM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1953-1965. PubMed ID: 30035646
[TBL] [Abstract][Full Text] [Related]
14. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
15. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles encapsulated in methacrylate coated gelatin with sustained release for specific medical applications.
Akhavan Farid E; Davachi SM; Pezeshki-Modaress M; Taranejoo S; Seyfi J; Hejazi I; Tabatabaei Hakim M; Najafi F; D'Amico C; Abbaspourrad A
J Biomater Sci Polym Ed; 2020 May; 31(7):910-937. PubMed ID: 32009574
[TBL] [Abstract][Full Text] [Related]
17. Regulation of particle morphology of pH-dependent poly(epsilon-caprolactone)-poly(gamma-glutamic acid) micellar nanoparticles to combat breast cancer cells.
Chan AS; Chen CH; Huang CM; Hsieh MF
J Nanosci Nanotechnol; 2010 Oct; 10(10):6283-97. PubMed ID: 21137721
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible Zr-based nanoscale MOFs coated with modified poly(ε-caprolactone) as anticancer drug carriers.
Filippousi M; Turner S; Leus K; Siafaka PI; Tseligka ED; Vandichel M; Nanaki SG; Vizirianakis IS; Bikiaris DN; Van Der Voort P; Van Tendeloo G
Int J Pharm; 2016 Jul; 509(1-2):208-218. PubMed ID: 27235556
[TBL] [Abstract][Full Text] [Related]
19. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
